How should hypertensive urgency be managed?

Management of Hypertensive Urgency

For hypertensive urgency (severely elevated BP >180/120 mmHg WITHOUT acute target organ damage), patients should be treated with oral antihypertensive medications and discharged after a brief observation period of at least 2 hours—NOT with intravenous medications or hospital admission. 1

Critical Distinction: Urgency vs Emergency

The fundamental management decision hinges on whether acute target organ damage is present:

• Hypertensive URGENCY: Severe BP elevation in stable patients WITHOUT acute or impending target organ damage 1
• Hypertensive EMERGENCY: Severe BP elevation WITH evidence of new or worsening target organ damage 2, 1

These are completely different clinical entities requiring opposite management approaches. The actual BP number matters less than the presence or absence of organ damage—patients with chronic hypertension can tolerate higher BP levels than previously normotensive individuals 2, 1.

Management Algorithm for Hypertensive Urgency

Step 1: Confirm the Diagnosis

• Verify BP measurements with multiple readings
• Rule out acute target organ damage (this is what determines urgency vs emergency):
  • No chest pain (acute coronary syndrome)
  • No dyspnea (pulmonary edema)
  • No neurological symptoms (stroke, encephalopathy)
  • No visual changes beyond chronic changes
  • No acute renal failure
  • No evidence of aortic dissection

Step 2: Identify Precipitating Factors

Common triggers to address 3:

• Medication nonadherence (most common—many patients have withdrawn from or are noncompliant with therapy) 1
• Acute pain or emotional stress
• Use of BP-elevating substances (NSAIDs, steroids, sympathomimetics, cocaine)

Step 3: Oral Medication Strategy

Reinstitute or intensify oral antihypertensive therapy 1. The ESC guidelines specifically recommend captopril, labetalol, or nifedipine retard (extended-release), though evidence is limited 3.

Critical pitfall to avoid: Do NOT use short-acting nifedipine—rapid BP falls can lead to cardiovascular complications including ischemic stroke 3.

Target BP reduction: Controlled reduction to safer levels without risk of hypotension. Rapid BP lowering is NOT recommended 3.

Step 4: Observation Period

• Observe for at least 2 hours after medication administration 3
• Monitor BP lowering efficacy and safety
• Assess for any development of symptoms suggesting organ damage

Step 5: Discharge Planning

• Arrange close outpatient follow-up (this is essential)
• Address medication adherence barriers
• Educate about warning signs requiring emergency return
• There is NO indication for emergency department referral, immediate BP reduction in the ED, or hospitalization for true hypertensive urgency 4

What NOT to Do in Hypertensive Urgency

The evidence strongly argues against aggressive treatment:

1. Do NOT use intravenous medications: Despite being common in practice (used in 81.6% of cases in one study 5), IV medications are NOT indicated for urgency and are associated with longer hospital stays without improved outcomes 5

2. Do NOT admit to hospital: Admission is only indicated for hypertensive EMERGENCY 2, 1

3. Do NOT rapidly lower BP: This increases risk of ischemic complications 3

Evidence Gaps and Practice Reality

Important caveat: A 2018 systematic review found only limited evidence for optimal treatment of hypertensive urgency, with just 262 participants across prospective controlled trials 6. The 2026 ESH-URGEM registry revealed significant gaps between guidelines and practice, showing that 35.1% of hypertensive urgency cases inappropriately received IV therapy, and 16.1% were hospitalized (often for non-hypertension-related conditions) 7.

Recent observational studies suggest potential harms from treating asymptomatic elevated inpatient BP 8, reinforcing the conservative approach recommended by guidelines.

Long-term Management Priority

The cardiovascular risk remains elevated after a hypertensive urgency 9. The real priority is establishing effective long-term BP control to prevent recurrent crises and reduce cardiovascular morbidity and mortality 10. This requires:

• Addressing adherence barriers
• Optimizing chronic antihypertensive regimen
• Close outpatient follow-up
• Screening for secondary hypertension if appropriate